{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:15:26Z","timestamp":1794366926436,"version":"4.9.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Special Topics on Basic and Applied Basic Research in Guangzhou","award":["SL2024A04J00648"],"award-info":[{"award-number":["SL2024A04J00648"]}]},{"name":"the joint funding project of schools (institutes) and enterprises in Guangzhou","award":["SL2024A03J00576"],"award-info":[{"award-number":["SL2024A03J00576"]}]},{"name":"Guangzhou Major Medical Disciplines Project","award":["2025-2027"],"award-info":[{"award-number":["2025-2027"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373239"],"award-info":[{"award-number":["82373239"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012534"],"award-info":[{"award-number":["2024A1515012534"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Director of Nanfang Hospital Foundation","award":["2022A005"],"award-info":[{"award-number":["2022A005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02613-w","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:55:08Z","timestamp":1772632508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["LncRNA NEAT1 promotes immunosuppression in gastric cancer under endoplasmic reticulum stress by maintaining the M6A methylation of SEMA3A in CAFs"],"prefix":"10.1186","volume":"25","author":[{"given":"Youqin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyuan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuxian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxin","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianbing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"2613_CR1","doi-asserted-by":"publisher","first-page":"100845","DOI":"10.1016\/j.ctarc.2024.100845","volume":"41","author":"TI Mamun","year":"2024","unstructured":"Mamun TI, Younus S, Rahman MH. Gastric cancer-epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: an updated review. Cancer Treat Res Commun. 2024;41:100845. https:\/\/doi.org\/10.1016\/j.ctarc.2024.100845.","journal-title":"Cancer Treat Res Commun"},{"key":"2613_CR2","doi-asserted-by":"publisher","first-page":"FSO842","DOI":"10.2144\/fsoa-2023-0002","volume":"9","author":"Y Yoshinami","year":"2023","unstructured":"Yoshinami Y, Shoji H. Recent advances in immunotherapy and molecular targeted therapy for gastric cancer. Future Sci OA. 2023;9:FSO842. https:\/\/doi.org\/10.2144\/fsoa-2023-0002.","journal-title":"Future Sci OA"},{"key":"2613_CR3","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1186\/s12885-024-12664-1","volume":"24","author":"L Yang","year":"2024","unstructured":"Yang L, Raveendran G, Meng X, Lin J, Meng Z. Predict progression free survival and overall survival using objective response rate for anti-PD1\/PDL1 therapy development. BMC Cancer. 2024;24:912. https:\/\/doi.org\/10.1186\/s12885-024-12664-1.","journal-title":"BMC Cancer"},{"key":"2613_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41575-022-00703-w","volume":"20","author":"M Alsina","year":"2023","unstructured":"Alsina M, Arrazubi V, Diez M, Tabernero J. Current developments in gastric cancer: from molecular profiling to treatment strategy. Nat Rev Gastroenterol Hepatol. 2023;20:155\u201370. https:\/\/doi.org\/10.1038\/s41575-022-00703-w.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2613_CR5","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1200\/JCO.22.02331","volume":"41","author":"MA Shah","year":"2023","unstructured":"Shah MA, Kennedy EB, Alarcon-Rozas AE, Alcindor T, Bartley AN, Malowany AB, et al. Immunotherapy and targeted therapy for advanced gastroesophageal cancer: ASCO guideline. J Clin Oncol. 2023;41:1470\u201391. https:\/\/doi.org\/10.1200\/JCO.22.02331.","journal-title":"J Clin Oncol"},{"key":"2613_CR6","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79:4557\u201366. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3962.","journal-title":"Cancer Res"},{"key":"2613_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41420-024-02110-3","volume":"10","author":"W Zhang","year":"2024","unstructured":"Zhang W, Shi Y, Oyang L, Cui S, Li S, Li J, et al. Endoplasmic reticulum stress-a key guardian in cancer. Cell Death Discov. 2024;10:343. https:\/\/doi.org\/10.1038\/s41420-024-02110-3.","journal-title":"Cell Death Discov"},{"key":"2613_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen X, Cubillos-Ruiz JR. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat Rev Cancer. 2021;21:71\u201388. https:\/\/doi.org\/10.1038\/s41568-020-00312-2.","journal-title":"Nat Rev Cancer"},{"key":"2613_CR9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.cell.2016.12.004","volume":"168","author":"JR Cubillos-Ruiz","year":"2017","unstructured":"Cubillos-Ruiz JR, Bettigole SE, Glimcher LH. Tumorigenic and immunosuppressive effects of endoplasmic reticulum stress in cancer. Cell. 2017;168:692\u2013706. https:\/\/doi.org\/10.1016\/j.cell.2016.12.004.","journal-title":"Cell"},{"key":"2613_CR10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/cac2.12416","volume":"43","author":"A Goenka","year":"2023","unstructured":"Goenka A, Khan F, Verma B, Sinha P, Dmello CC, Jogalekar MP, et al. Tumor microenvironment signaling and therapeutics in cancer progression. Cancer Commun (Lond). 2023;43:525\u201361. https:\/\/doi.org\/10.1002\/cac2.12416.","journal-title":"Cancer Commun (Lond)"},{"key":"2613_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.it.2018.12.001","volume":"40","author":"M Song","year":"2019","unstructured":"Song M, Cubillos-Ruiz JR. Endoplasmic reticulum stress responses in intratumoral immune cells: implications for cancer immunotherapy. Trends Immunol. 2019;40:128\u201341. https:\/\/doi.org\/10.1016\/j.it.2018.12.001.","journal-title":"Trends Immunol"},{"key":"2613_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.canlet.2019.01.034","volume":"449","author":"Y Wang","year":"2019","unstructured":"Wang Y, Wang K, Jin Y, Sheng X. Endoplasmic reticulum proteostasis control and gastric cancer. Cancer Lett. 2019;449:263\u201371. https:\/\/doi.org\/10.1016\/j.canlet.2019.01.034.","journal-title":"Cancer Lett"},{"key":"2613_CR13","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1158\/1078-0432.CCR-22-1031","volume":"29","author":"KB Kennel","year":"2023","unstructured":"Kennel KB, Bozlar M, De Valk AF, Greten FR. Cancer-associated fibroblasts in inflammation and antitumor immunity. Clin Cancer Res. 2023;29:1009\u201316. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-1031.","journal-title":"Clin Cancer Res"},{"key":"2613_CR14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","volume":"3","author":"D Lavie","year":"2022","unstructured":"Lavie D, Ben-Shmuel A, Erez N, Scherz-Shouval R. Cancer-associated fibroblasts in the single-cell era. Nat Cancer. 2022;3:793\u2013807. https:\/\/doi.org\/10.1038\/s43018-022-00411-z.","journal-title":"Nat Cancer"},{"key":"2613_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10555-024-10233-3","volume":"44","author":"Y De Oliveira Macena","year":"2024","unstructured":"De Oliveira Macena Y, Cezar MEN, Lira CBF, De Oliveira L, Almeida TN, Costa A, et al. The roles of periostin derived from cancer-associated fibroblasts in tumor progression and treatment response. Cancer Metastasis Rev. 2024;44:11. https:\/\/doi.org\/10.1007\/s10555-024-10233-3.","journal-title":"Cancer Metastasis Rev"},{"key":"2613_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41577-024-01050-4","volume":"24","author":"A Altieri","year":"2024","unstructured":"Altieri A, Buechler MB. Breast cancer-associated fibroblasts maintain self-renewing immunosuppressive macrophages. Nat Rev Immunol. 2024;24:459. https:\/\/doi.org\/10.1038\/s41577-024-01050-4.","journal-title":"Nat Rev Immunol"},{"key":"2613_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","volume":"12","author":"S Affo","year":"2017","unstructured":"Affo S, Yu LX, Schwabe RF. The role of cancer-associated fibroblasts and fibrosis in liver cancer. Annu Rev Pathol. 2017;12:153\u201386. https:\/\/doi.org\/10.1146\/annurev-pathol-052016-100322.","journal-title":"Annu Rev Pathol"},{"key":"2613_CR18","doi-asserted-by":"publisher","first-page":"e2217612120","DOI":"10.1073\/pnas.2217612120","volume":"120","author":"S Rogers","year":"2023","unstructured":"Rogers S, Zhang C, Anagnostidis V, Liddle C, Fishel ML, Gielen F, et al. Cancer-associated fibroblasts influence Wnt\/PCP signaling in gastric cancer cells by cytoneme-based dissemination of ROR2. Proc Natl Acad Sci U S A. 2023;120:e2217612120. https:\/\/doi.org\/10.1073\/pnas.2217612120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2613_CR19","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1038\/s41467-023-39953-w","volume":"14","author":"E Koncina","year":"2023","unstructured":"Koncina E, Nurmik M, Pozdeev VI, Gilson C, Tsenkova M, Begaj R, et al. IL1R1(+) cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer. Nat Commun. 2023;14:4251. https:\/\/doi.org\/10.1038\/s41467-023-39953-w.","journal-title":"Nat Commun"},{"key":"2613_CR20","doi-asserted-by":"publisher","first-page":"16779","DOI":"10.1038\/s41598-021-96344-1","volume":"11","author":"KW Min","year":"2021","unstructured":"Min KW, Kim DH, Noh YK, Son BK, Kwon MJ, Moon JY. Cancer-associated fibroblasts are associated with poor prognosis in solid type of lung adenocarcinoma in a machine learning analysis. Sci Rep. 2021;11:16779. https:\/\/doi.org\/10.1038\/s41598-021-96344-1.","journal-title":"Sci Rep"},{"key":"2613_CR21","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1158\/0008-5472.CAN-24-2448","volume":"84","author":"G Mucciolo","year":"2024","unstructured":"Mucciolo G, Li W, Biffi G. Cancer-associated fibroblasts: from spectators to protagonists in pancreatic cancer progression. Cancer Res. 2024;84:2938\u201340. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-2448.","journal-title":"Cancer Res"},{"key":"2613_CR22","doi-asserted-by":"publisher","first-page":"889","DOI":"10.20517\/cdr.2022.67","volume":"5","author":"W Wang","year":"2022","unstructured":"Wang W, Cheng B, Yu Q. Cancer-associated fibroblasts as accomplices to confer therapeutic resistance in cancer. Cancer Drug Resist. 2022;5:889\u2013901. https:\/\/doi.org\/10.20517\/cdr.2022.67.","journal-title":"Cancer Drug Resist"},{"key":"2613_CR23","doi-asserted-by":"publisher","first-page":"113947","DOI":"10.1016\/j.yexcr.2024.113947","volume":"435","author":"H Wang","year":"2024","unstructured":"Wang H, Liu F, Wu X, Zhu G, Tang Z, Qu W, et al. Cancer-associated fibroblasts contributed to hepatocellular carcinoma recurrence and metastasis via CD36-mediated fatty-acid metabolic reprogramming. Exp Cell Res. 2024;435:113947. https:\/\/doi.org\/10.1016\/j.yexcr.2024.113947.","journal-title":"Exp Cell Res"},{"key":"2613_CR24","doi-asserted-by":"publisher","first-page":"6359","DOI":"10.1002\/jcp.26433","volume":"233","author":"Y Sun","year":"2018","unstructured":"Sun Y, Wang R, Qiao M, Xu Y, Guan W, Wang L. Cancer associated fibroblasts tailored tumor microenvironment of therapy resistance in gastrointestinal cancers. J Cell Physiol. 2018;233:6359\u201369. https:\/\/doi.org\/10.1002\/jcp.26433.","journal-title":"J Cell Physiol"},{"key":"2613_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20:131. https:\/\/doi.org\/10.1186\/s12943-021-01428-1.","journal-title":"Mol Cancer"},{"key":"2613_CR26","doi-asserted-by":"publisher","first-page":"8840066","DOI":"10.1155\/2021\/8840066","volume":"2021","author":"J Soongsathitanon","year":"2021","unstructured":"Soongsathitanon J, Jamjuntra P, Sumransub N, Yangngam S, De la Fuente M, Landskron G, et al. Crosstalk between tumor-infiltrating immune cells and cancer-associated fibroblasts in tumor growth and immunosuppression of breast cancer. J Immunol Res. 2021;2021:8840066. https:\/\/doi.org\/10.1155\/2021\/8840066.","journal-title":"J Immunol Res"},{"key":"2613_CR27","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41419-021-03991-3","volume":"12","author":"J Guo","year":"2021","unstructured":"Guo J, Zhong X, Tan Q, Yang S, Liao J, Zhuge J, et al. miR-301a-3p induced by endoplasmic reticulum stress mediates the occurrence and transmission of trastuzumab resistance in HER2-positive gastric cancer. Cell Death Dis. 2021;12:696. https:\/\/doi.org\/10.1038\/s41419-021-03991-3.","journal-title":"Cell Death Dis"},{"key":"2613_CR28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41698-021-00207-x","volume":"5","author":"Y Qin","year":"2021","unstructured":"Qin Y, Zuo Q, Huang L, Huang L, Merlino G, Yu Y. PERK mediates resistance to BRAF inhibition in melanoma with impaired PTEN. npj Precis Oncol. 2021;5:68. https:\/\/doi.org\/10.1038\/s41698-021-00207-x.","journal-title":"npj Precis Oncol"},{"key":"2613_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s10120-023-01456-4","volume":"27","author":"C Tsutsumi","year":"2024","unstructured":"Tsutsumi C, Ohuchida K, Katayama N, Yamada Y, Nakamura S, Okuda S, et al. Tumor-infiltrating monocytic myeloid-derived suppressor cells contribute to the development of an immunosuppressive tumor microenvironment in gastric cancer. Gastric Cancer. 2024;27:248\u201362. https:\/\/doi.org\/10.1007\/s10120-023-01456-4.","journal-title":"Gastric Cancer"},{"key":"2613_CR30","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/2159-8290.CD-21-0683","volume":"12","author":"V Kumar","year":"2022","unstructured":"Kumar V, Ramnarayanan K, Sundar R, Padmanabhan N, Srivastava S, Koiwa M, et al. Single-cell atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer. Cancer Discov. 2022;12:670\u201391. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0683.","journal-title":"Cancer Discov"},{"key":"2613_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.stem.2020.11.006","volume":"28","author":"H Wang","year":"2021","unstructured":"Wang H, He J, Xu C, Chen X, Yang H, Shi S, et al. Decoding human megakaryocyte development. Cell Stem Cell. 2021;28:535-549 e538. https:\/\/doi.org\/10.1016\/j.stem.2020.11.006.","journal-title":"Cell Stem Cell"},{"key":"2613_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13059-020-1950-6","volume":"21","author":"S Yang","year":"2020","unstructured":"Yang S, Corbett SE, Koga Y, Wang Z, Johnson WE, Yajima M, et al. Decontamination of ambient RNA in single-cell RNA-seq with DecontX. Genome Biol. 2020;21:57. https:\/\/doi.org\/10.1186\/s13059-020-1950-6.","journal-title":"Genome Biol"},{"key":"2613_CR33","doi-asserted-by":"publisher","first-page":"e730","DOI":"10.1002\/ctm2.730","volume":"12","author":"H Jiang","year":"2022","unstructured":"Jiang H, Yu D, Yang P, Guo R, Kong M, Gao Y, et al. Revealing the transcriptional heterogeneity of organ-specific metastasis in human gastric cancer using single-cell RNA sequencing. Clin Transl Med. 2022;12:e730. https:\/\/doi.org\/10.1002\/ctm2.730.","journal-title":"Clin Transl Med"},{"key":"2613_CR34","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"Zhang L, Yu X, Zheng L, Zhang Y, Li Y, Fang Q, et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature. 2018;564:268\u201372. https:\/\/doi.org\/10.1038\/s41586-018-0694-x.","journal-title":"Nature"},{"key":"2613_CR35","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/gutjnl-2024-332901","volume":"74","author":"SH Lee","year":"2025","unstructured":"Lee SH, Lee D, Choi J, Oh HJ, Ham IH, Ryu D, et al. Spatial dissection of tumour microenvironments in gastric cancers reveals the immunosuppressive crosstalk between CCL2+ fibroblasts and STAT3-activated macrophages. Gut. 2025;74:714\u201327. https:\/\/doi.org\/10.1136\/gutjnl-2024-332901.","journal-title":"Gut"},{"key":"2613_CR36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","volume":"40","author":"DM Cable","year":"2022","unstructured":"Cable DM, Murray E, Zou LS, Goeva A, Macosko EZ, Chen F, et al. Robust decomposition of cell type mixtures in spatial transcriptomics. Nat Biotechnol. 2022;40:517\u201326. https:\/\/doi.org\/10.1038\/s41587-021-00830-w.","journal-title":"Nat Biotechnol"},{"key":"2613_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13059-022-02663-5","volume":"23","author":"J Tanevski","year":"2022","unstructured":"Tanevski J, Flores ROR, Gabor A, Schapiro D, Saez-Rodriguez J. Explainable multiview framework for dissecting spatial relationships from highly multiplexed data. Genome Biol. 2022;23:97. https:\/\/doi.org\/10.1186\/s13059-022-02663-5.","journal-title":"Genome Biol"},{"key":"2613_CR38","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/s41423-021-00637-4","volume":"18","author":"F Liu","year":"2021","unstructured":"Liu F, Wang C, Huang H, Yang Y, Dai L, Han S, et al. SEMA3A-mediated crosstalk between prostate cancer cells and tumor-associated macrophages promotes androgen deprivation therapy resistance. Cell Mol Immunol. 2021;18:752\u20134. https:\/\/doi.org\/10.1038\/s41423-021-00637-4.","journal-title":"Cell Mol Immunol"},{"key":"2613_CR39","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1038\/s41467-024-47424-z","volume":"15","author":"MB Barnkob","year":"2024","unstructured":"Barnkob MB, Michaels YS, Andre V, Macklin PS, Gileadi U, Valvo S, et al. Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8(+) T cells. Nat Commun. 2024;15:3173. https:\/\/doi.org\/10.1038\/s41467-024-47424-z.","journal-title":"Nat Commun"},{"key":"2613_CR40","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ccr.2013.11.007","volume":"24","author":"A Casazza","year":"2013","unstructured":"Casazza A, Laoui D, Wenes M, Rizzolio S, Bassani N, Mambretti M, et al. Impeding macrophage entry into hypoxic tumor areas by Sema3A\/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity. Cancer Cell. 2013;24:695\u2013709. https:\/\/doi.org\/10.1016\/j.ccr.2013.11.007.","journal-title":"Cancer Cell"},{"key":"2613_CR41","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-020-01207-4","volume":"19","author":"Y Chen","year":"2020","unstructured":"Chen Y, Lin Y, Shu Y, He J, Gao W. Interaction between N(6)-methyladenosine (m(6)A) modification and noncoding RNAs in cancer. Mol Cancer. 2020;19:94. https:\/\/doi.org\/10.1186\/s12943-020-01207-4.","journal-title":"Mol Cancer"},{"key":"2613_CR42","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1101\/gad.351913.124","volume":"38","author":"V Mamontova","year":"2024","unstructured":"Mamontova V, Trifault B, Gribling-Burrer AS, Bohn P, Boten L, Preckwinkel P, et al. NEAT1 promotes genome stability via m(6)A methylation-dependent regulation of CHD4. Genes Dev. 2024;38:915\u201330. https:\/\/doi.org\/10.1101\/gad.351913.124.","journal-title":"Genes Dev"},{"key":"2613_CR43","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1111\/cas.14439","volume":"111","author":"S Liu","year":"2020","unstructured":"Liu S, Chen L, Zhao H, Li Q, Hu R, Wang H. Integrin beta8 facilitates tumor growth and drug resistance through a Y-box binding protein 1-dependent signaling pathway in bladder cancer. Cancer Sci. 2020;111:2423\u201330. https:\/\/doi.org\/10.1111\/cas.14439.","journal-title":"Cancer Sci"},{"key":"2613_CR44","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1083\/jcb.201702033","volume":"216","author":"Y Attieh","year":"2017","unstructured":"Attieh Y, Clark AG, Grass C, Richon S, Pocard M, Mariani P, et al. Cancer-associated fibroblasts lead tumor invasion through integrin-beta3-dependent fibronectin assembly. J Cell Biol. 2017;216:3509\u201320. https:\/\/doi.org\/10.1083\/jcb.201702033.","journal-title":"J Cell Biol"},{"key":"2613_CR45","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.apsb.2021.01.004","volume":"11","author":"M Li","year":"2021","unstructured":"Li M, Wang Y, Li M, Wu X, Setrerrahmane S, Xu H. Integrins as attractive targets for cancer therapeutics. Acta Pharm Sin B. 2021;11:2726\u201337. https:\/\/doi.org\/10.1016\/j.apsb.2021.01.004.","journal-title":"Acta Pharm Sin B"},{"key":"2613_CR46","doi-asserted-by":"publisher","unstructured":"Sharma M, Turaga RC, Yuan Y, Satyanarayana G, Mishra F, Bian Z, Liu W, Sun L, Yang J, Liu ZR. Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC. J Exp Med. 2021;218. https:\/\/doi.org\/10.1084\/jem.20200712.","DOI":"10.1084\/jem.20200712"},{"key":"2613_CR47","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12943-024-02092-x","volume":"23","author":"S Cousin","year":"2024","unstructured":"Cousin S, Guegan JP, Shitara K, Palmieri LJ, Metges JP, Pernot S, et al. Identification of microenvironment features associated with primary resistance to anti-PD-1\/PD-L1 + antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics. Mol Cancer. 2024;23:197. https:\/\/doi.org\/10.1186\/s12943-024-02092-x.","journal-title":"Mol Cancer"},{"key":"2613_CR48","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41419-024-07049-y","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang X, Fan Y, Tan K. A bird\u2019s eye view of mitochondrial unfolded protein response in cancer: mechanisms, progression and further applications. Cell Death Dis. 2024;15:667. https:\/\/doi.org\/10.1038\/s41419-024-07049-y.","journal-title":"Cell Death Dis"},{"key":"2613_CR49","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/1471-2407-12-421","volume":"12","author":"HW King","year":"2012","unstructured":"King HW, Michael MZ, Gleadle JM. Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer. 2012;12:421. https:\/\/doi.org\/10.1186\/1471-2407-12-421.","journal-title":"BMC Cancer"},{"key":"2613_CR50","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41590-024-01828-7","volume":"25","author":"ACY Chen","year":"2024","unstructured":"Chen ACY, Jaiswal S, Martinez D, Yerinde C, Ji K, Miranda V, et al. The aged tumor microenvironment limits T cell control of cancer. Nat Immunol. 2024;25:1033\u201345. https:\/\/doi.org\/10.1038\/s41590-024-01828-7.","journal-title":"Nat Immunol"},{"key":"2613_CR51","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1136\/gutjnl-2018-316324","volume":"68","author":"C Lin","year":"2019","unstructured":"Lin C, He H, Liu H, Li R, Chen Y, Qi Y, et al. Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer. Gut. 2019;68:1764\u201373. https:\/\/doi.org\/10.1136\/gutjnl-2018-316324.","journal-title":"Gut"},{"key":"2613_CR52","doi-asserted-by":"publisher","first-page":"215598","DOI":"10.1016\/j.canlet.2022.215598","volume":"532","author":"X Zhou","year":"2022","unstructured":"Zhou X, Fang D, Liu H, Ou X, Zhang C, Zhao Z, et al. PMN-MDSCs accumulation induced by CXCL1 promotes CD8(+) T cells exhaustion in gastric cancer. Cancer Lett. 2022;532:215598. https:\/\/doi.org\/10.1016\/j.canlet.2022.215598.","journal-title":"Cancer Lett"},{"key":"2613_CR53","doi-asserted-by":"publisher","unstructured":"Kim EY, Abdul-Ghafar J, Chong Y, Yim K. Calculated tumor-associated neutrophils are associated with the tumor-stroma ratio and predict a poor prognosis in advanced gastric cancer. Biomedicines. 2022;10. https:\/\/doi.org\/10.3390\/biomedicines10030708.","DOI":"10.3390\/biomedicines10030708"},{"key":"2613_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, Deng T, Liu R, Ning T, Yang H, Liu D, et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020;19:43. https:\/\/doi.org\/10.1186\/s12943-020-01168-8.","journal-title":"Mol Cancer"},{"key":"2613_CR55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41571-021-00552-7","volume":"19","author":"L Kraehenbuehl","year":"2022","unstructured":"Kraehenbuehl L, Weng CH, Eghbali S, Wolchok JD, Merghoub T. Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways. Nat Rev Clin Oncol. 2022;19:37\u201350. https:\/\/doi.org\/10.1038\/s41571-021-00552-7.","journal-title":"Nat Rev Clin Oncol"},{"key":"2613_CR56","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/imm.13058","volume":"157","author":"MA Moreno Ayala","year":"2019","unstructured":"Moreno Ayala MA, Li Z, DuPage M. Treg programming and therapeutic reprogramming in cancer. Immunology. 2019;157:198\u2013209. https:\/\/doi.org\/10.1111\/imm.13058.","journal-title":"Immunology"},{"key":"2613_CR57","doi-asserted-by":"publisher","first-page":"eabf8495","DOI":"10.1126\/scitranslmed.abf8495","volume":"13","author":"CA Chuckran","year":"2021","unstructured":"Chuckran CA, Cillo AR, Moskovitz J, Overacre-Delgoffe A, Somasundaram AS, Shan F, et al. Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer. Sci Transl Med. 2021;13:eabf8495. https:\/\/doi.org\/10.1126\/scitranslmed.abf8495.","journal-title":"Sci Transl Med"},{"key":"2613_CR58","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1097\/HEP.0000000000000320","volume":"78","author":"Q Wu","year":"2023","unstructured":"Wu Q, Pan C, Zhou Y, Wang S, Xie L, Zhou W, et al. Targeting neuropilin-1 abolishes anti-PD-1-upregulated regulatory T cells and synergizes with 4\u20131BB agonist for liver cancer treatment. Hepatology. 2023;78:1402\u201317. https:\/\/doi.org\/10.1097\/HEP.0000000000000320.","journal-title":"Hepatology"},{"key":"2613_CR59","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.kint.2021.10.034","volume":"101","author":"A Calmont","year":"2022","unstructured":"Calmont A. Sema4A-Nrp1 versus Sema4A-plexinB2 in the acutely damaged kidney. Kidney Int. 2022;101:419. https:\/\/doi.org\/10.1016\/j.kint.2021.10.034.","journal-title":"Kidney Int"},{"key":"2613_CR60","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2174\/1566524023666230801124826","volume":"24","author":"H Yang","year":"2024","unstructured":"Yang H, Zhou Y, Wang L, Lv M, Sun J, Luo Z, et al. Sema3A alleviates the malignant behaviors of gastric cancer cells by inhibiting NRP-1. Curr Mol Med. 2024;24:931\u20139. https:\/\/doi.org\/10.2174\/1566524023666230801124826.","journal-title":"Curr Mol Med"},{"key":"2613_CR61","doi-asserted-by":"publisher","first-page":"121499","DOI":"10.1016\/j.lfs.2023.121499","volume":"318","author":"C Bica","year":"2023","unstructured":"Bica C, Tirpe A, Nutu A, Ciocan C, Chira S, Gurzau ES, et al. Emerging roles and mechanisms of semaphorins activity in cancer. Life Sci. 2023;318:121499. https:\/\/doi.org\/10.1016\/j.lfs.2023.121499.","journal-title":"Life Sci"},{"key":"2613_CR62","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41392-021-00779-x","volume":"6","author":"C Li","year":"2021","unstructured":"Li C, Ni YQ, Xu H, Xiang QY, Zhao Y, Zhan JK, et al. Roles and mechanisms of exosomal non-coding RNAs in human health and diseases. Signal Transduct Target Ther. 2021;6:383. https:\/\/doi.org\/10.1038\/s41392-021-00779-x.","journal-title":"Signal Transduct Target Ther"},{"key":"2613_CR63","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12943-020-01278-3","volume":"19","author":"Z Xu","year":"2020","unstructured":"Xu Z, Zeng S, Gong Z, Yan Y. Exosome-based immunotherapy: a promising approach for cancer treatment. Mol Cancer. 2020;19:160. https:\/\/doi.org\/10.1186\/s12943-020-01278-3.","journal-title":"Mol Cancer"},{"key":"2613_CR64","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41419-024-06593-x","volume":"15","author":"L Wang","year":"2024","unstructured":"Wang L, Qiao C, Han L, Wang X, Miao J, Cao L, et al. HOXD3 promotes the migration and angiogenesis of hepatocellular carcinoma via modifying hepatocellular carcinoma cells exosome-delivered CCR6 and regulating chromatin conformation of CCL20. Cell Death Dis. 2024;15:221. https:\/\/doi.org\/10.1038\/s41419-024-06593-x.","journal-title":"Cell Death Dis"},{"key":"2613_CR65","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12943-021-01411-w","volume":"20","author":"C Jiang","year":"2021","unstructured":"Jiang C, Zhang N, Hu X, Wang H. Tumor-associated exosomes promote lung cancer metastasis through multiple mechanisms. Mol Cancer. 2021;20:117. https:\/\/doi.org\/10.1186\/s12943-021-01411-w.","journal-title":"Mol Cancer"},{"key":"2613_CR66","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-019-0991-5","volume":"18","author":"L Mashouri","year":"2019","unstructured":"Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F, Alahari SK. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer. 2019;18:75. https:\/\/doi.org\/10.1186\/s12943-019-0991-5.","journal-title":"Mol Cancer"},{"key":"2613_CR67","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41392-020-00359-5","volume":"5","author":"E Yang","year":"2020","unstructured":"Yang E, Wang X, Gong Z, Yu M, Wu H, Zhang D. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression. Signal Transduct Target Ther. 2020;5:242. https:\/\/doi.org\/10.1038\/s41392-020-00359-5.","journal-title":"Signal Transduct Target Ther"},{"key":"2613_CR68","doi-asserted-by":"publisher","first-page":"e2309298","DOI":"10.1002\/advs.202309298","volume":"11","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhang J, Shi H, Wang M, Yu D, Fu M, et al. M2 tumor-associated macrophages-derived exosomal MALAT1 promotes glycolysis and gastric cancer progression. Adv Sci (Weinh). 2024;11:e2309298. https:\/\/doi.org\/10.1002\/advs.202309298.","journal-title":"Adv Sci (Weinh)"},{"key":"2613_CR69","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41419-022-05240-7","volume":"13","author":"P Yang","year":"2022","unstructured":"Yang P, Zhang D, Wang T, Ji J, Jin C, Peng C, et al. CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway. Cell Death Dis. 2022;13:796. https:\/\/doi.org\/10.1038\/s41419-022-05240-7.","journal-title":"Cell Death Dis"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02613-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02613-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02613-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:16:28Z","timestamp":1775819788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02613-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2613"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02613-w","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animals were treated in accordance with the committee of Nanfang Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}